SEROLOGICAL STUDY OF BULGARIAN PATIENTS WITH BRUCELLOSIS
DOI:
https://doi.org/10.58395/pipd.v49i2.48Keywords:
brucellosis, serological tests, incomplete antibodies, outbreakAbstract
Background: Brucellosis is a widespread zoonotic infection with significant health and socio-economic impacts. This determines the need of a reliable laboratory diagnosis both in endemic areas around the world and in countries where it is rare and under diagnosed. Due to prolongedand hazardous cultivation procedures, the diagnosis is mostly serologically confirmed.
Aim: Serological study of Bulgarian citizens with clinical and/or epidemiological data compatible to brucellosis for the period 2005-2015.
Materials and methods: Based on clinical and epidemiological data obtained via standard questionnaire 3394 persons suspected for brucellosis along with 106 controls were serologically studied with Rose Bengal slide test, Standard agglutination test, Coombs’ test, Brucellacapt and ELISA.
Results: Brucellosis was confirmed in 174 patients. In outbreak related cases the tests listed above were positive in 127 (78.88%), 115 (71.43%), 34 (91.98%), 143 (95.33%) and 104 (96.30%), respectively. A statistically significant positive correlation was found between Coombs’ and Brucellacapt in the studied 55 sera samples (rs = 0,72; p < 0,0000). The profile of anti-Brucella antibodies was investigated in 46 patients with different duration of the disease. In 29 (63.0%) of them the initial serum sample was positive for the three classes of antibodies and in 17 (36.9%) the primary testing didn’t detect IgM, but IgG and IgA.
Conclusion: None of the serological tests alone could ensure an accurate diagnosis of brucellosis. It is necessary to use a diagnostic algorithm with appropriately selected serological tests in which Brucellacapt could successfully replace Coombs' test´ for detection of incomplete antibodies in brucellosis with long duration.
Downloads
References
Food and Agriculture Organization of the United Nations, World Organisation of Animal Health, and World Health Organization. Brucellosis in Human and Animals. Geneva: World Health Organization,. WHO/CDS/EPR/2006.7. http://www.who.int/entity/csr/resources/publications/Brucellosis
Pappas G, Papadimitriou P, Akritidis N, et al. The new global map of human brucellosis. Lancet Infect Dis. 2006;6(2):91-9.
WHO. The control of neglected zoonotic diseases: from advocacy to action report of the fourth international meeting held at WHO headquarters, Geneva, Switzerland. Geneva. 2015. p. 44.
Cross AR, Baldwin VM, Roy S, et al. Zoonoses under our noses. Microbes Infect. 2019;21(1):10-19.
European Center for Disease Prevention and Control. Annual Epidemiological Report 2017: food-and waterborne diseases and zoonoses. Stockholm, ECDC, 2017. Available from
https://www.ecdc.europa.eu/en/publications-data/brucellosis-annual-epidemiological-report-2017
(Accessed 19 Jun 2019).
Talevski V, Zera L, Kantardjiev T, et al. An overview of the epidemiology and epizootology of brucellosis in selected countries of Central and Southeast Europe. Vet Microbiol. 2002;90(1-4):147-55.
Mersini K, Alla L, Juma A, et al. Review of brucellosis in Albania: disease frequency in humans and animals, and one health efforts to control the disease, 1925 to present. IJID. 2019;79(S1):3–4.
Fero E, Juma A, Koni A, et al. The seroprevalence of brucellosis and molecular haracterization of Brucella species circulating in the beef cattle herds in Albania. PLoS ONE 2020;15(3): e0229741. https://doi.org/10.1371/journal.pone.0229741.
Arapović J, Špičić S, Ostojić M, et al. Clinical and Molecular Characterization of Human Brucellosis in Bosnia and Herzegovina - An Ongoing Brucellosis Outbreak. Acta Med Acad. 2018;47(1):50-60.
Fouskis I, Sandalakisa V, Christidoua A, et al. The epidemiology of Brucellosis in Greece, 2007–2012: a ‘One Health’ approach. Trans R Soc Trop Med Hyg. 2018; 112(3):124-135.
Ivanov IN, Nenova R, Panaiotov S, et al. Clinical management of travel-associated brucellosis cases in Bulgaria. Probl. Inf. Parasit. Dis. 2010;38(1):15-18.
Russo G, Pasquali P, Nenova R et al. Reemergence of human and animal brucellosis in Bulgaria. Emerg. Infect. Dis. 2009;15:314-316.
Norman FF, Monge-Maillo B, Chamorro-Tojeiro S, Pérez-Molina JA, López-Vélez R. Imported brucellosis: A case series and literature review. Travel Med Infect Dis. 2016;14(3):182-99.
Enkelmann J, Stark K, Faber M. Epidemiological trends of notified human brucellosis in Germany, 2006–2018. IGID. 2020;93:353–358.
Lytras T, Danis K, Dounias G. Incidence patterns and occupational risk factors of human brucellosis in Greece, 2004–2015. Int J Occup Environ Med. 2016;7:221-226.
Nenova R, Tomova I, Saparevska R, et al. A new outbreak of brucellosis in Bulgaria detected in July 2015 – preliminary report. Euro Surveill. 2015;20(39):pii=30031. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2015.20.39.30031
Nenova R, Tomova I. Brucellosis - an unknown and un derdiagnosed infection in Bulgaria. Probl. Inf. Parasit. Dis. 2017;45(1):5-14.
Official Journal of the European Union, L 170, 6.7.2018, p. 12. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32018D0945&from=EN#page=12
Al Dahouk S, Tomaso H, Nöckler K, et al. Laboratory-based Diagnosis of Brucellosis - A Review of the Literature. Part II: Serological Tests for Brucellosis. Clin. Lab. 2003;49:577-589.
Diaz R, Casanova A, Ariza J, et al. The Rose Bengal Test in Human Brucellosis: A Neglected Test for the Diagnosis of a Neglected Disease. PLoS Negl Trop Dis 2011;5(4):e950.doi:10.1371/journal.pntd.0000950.
Ruiz-Mesa JD, Sanchez-Gonzalez J, Reguera JM et al. Rose Bengal test: diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic areas. Clin Microbiol Infect. 2005;11:221–25.
Irmak H, Buzgan T, Evirgen Ö et al. Use of the Brucella IgM and IgG flow assays in the serodiagnosis of human brucellosis in an area endemic for brucellosis. Am. J. Trop. Med. Hyg. 2004;70: 688–694.
Araj G. Brucella, p. 863-872. In: Jorgensen J, Pfaller M. (ed.), Bergey's Manual of Systematic Bacteriology, vol. 1. Springer 2015.
Araj GF, Lulu AR, Khateeb MI et al. ELISA versus routine tests in the diagnosis of patients with systemic and neurobrucellosis. APMIS. 1988;96:171–176.
Al Dahouk S, Sprague LD, Neubauer H. New developments in the diagnostic procedures for zoonotic brucellosis in humans. Rev.sci.tech. Off. int. Epiz. 2013;32(1):177-188.
Centers for Disease Control and Prevention. 2010. Brucellosis (Brucella spp.) Case Definition. https://wwwn.cdc.gov/nndss/conditions/brucellosis/case-definition/2010/
Orduña A, Almarza A, Prado A, et al. Evaluation of immunocapture-agglutination test (Brucellacapt) for serodiagnosis. J. Clin. Microbiol. 2000;38(11):4000-4005.
Casao MA, Navarro E, Solera J. Evaluation of Brucellacapt for the diagnosis of human brucellosis. J. Infect. 2004;49:102–108.
Mert A, Ozaras R, Tabak F, et al. The sensitivity and specificity of Brucella agglutination tests. Diagn. Microbiol.Infect. Dis. 2003;46:241–243.
Mohsenpour B., Afrasiabian S, Hajibagheri K, et al. Is Wright Test an Appropriate Screening Test for Diagnosis of Brucellosis? Am. J. Infect. Dis. 2011;7(2):28-31.
Clavijo E, Díaz R, Anguita A, et al. Comparison of a Dipstick Assay for Detection of Brucella-Specific Immunoglobulin M Antibodies with Other Tests for Serodiagnosis of Human Brucellosis. Clin. Diagn. Lab. Immunol. 2003;10(4):612-615.
Amirzargar AA, Hassibi M, Maleknejad P, et al. Comparison of diagnostic methods in hospitalized patients with brucellosis in Iran. Infect. Dis. Clin. Pract. 2009;17(4):239-242.
Hajia M, Rahbar M, Taghavi HA. Brucellosis antibody level of hospitalized patients in Hamadan, Western Iran. Shiraz E Med. J. 2007;8. https://sites.kowsarpub.com/semj/result.html
Hajia M, Fallah F, Angoti G, et al. Comparison of Methods for Diagnosing Brucellosis. Lab Med. 2013;44(1):29-33.
Casanova A, Ariza J, Rubio M, et al. Brucellacapt versus classical tests in the serological diagnosis and management of human brucellosis. Clin. vaccine Immunol. 2009;16(6):844–851.
Mantur BG, Amarnath SK, Parande AM, et al. Comparison of a novel immunocapture assay with standard serological methods in the diagnosis of brucellosis. Clin. Lab. 2011;57:333-341.
Orduña A, Almarza A, Prado A, et al. Evaluation of immunocapture-agglutination test (Brucellacapt) for serodiagnosis. J. Clin. Microbiol. 2000;38(11):4000-4005.
Serra J, Velasco J, Godoy P, et al. Can the Brucellacapt® test be substituted for the Coombs test in the diagnosis of human brucellosis? Enferm Infecc Microbiol Clin. 2001;19(5):202-205. (in Spanish)
Ariza J, Pellicer T, Pallares R, et al. Specific antibody profile in human brucellosis. Clin Infect Dis. 1992;14:131-140.
Araj GF, Lulu AR, Mustafa MY, et al. Evaluation of ELISA in the diagnosis of acute and chronic brucellosis in human beings. Hyg. 1986;97:457–469.
Gomez MC, Nieto J, Rosa C, et al. Evaluation of Seven Tests for Diagnosis of Human Brucellosis in an Area Where the Disease Is Endemic. Clin. Vaccine Immunol. 2008;15(6):1031-1033.
Pellicer T, Ariza A. Foz R, et al. Specific antibodies during relapse of human brucellosis. J. Infect. Dis. 1988;157:918–924.
Smits HL, Basahi MA, Diaz R,. et al. Development and evaluation of rapid dipstick assay for serodiagnosis of acute human brucellosis. J. Clin. Microbiol. 1999;37:4179–4182.
Lulu AR, Araj GF, Khatecb ML. Human brucellosis in Kuwait: a prospective study of 400 cases. Q J Med 1988;66:39-54.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Iskra Tomova, Assist.Prof. Rumiana Nenova, MD, PhD, Liliya Goryanova (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
